AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25277390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (210 IU and 420 IU)
Number of subjects: 20
Study 25277390 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of ins‐asp (0.12 IU/kg/24 h)
Number of subjects: 20
Study 23620931 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance needling therapy
Number of subjects: 60
Study 23620931 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional acupuncture
Number of subjects: 60
Study 23620931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21148517 — intervention group
Group type: EXPERIMENTAL
Intervention: Telavancin (10 mg/kg every 24 h)
Number of subjects: 1503
Study 21148517 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (1 g every 12 h)
Number of subjects: 1503
Study 21148517 — intervention group
Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 1503
Study 21148517 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1503
Study 18093662 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 300-800 mg/daily (mean final dose 461.6 mg/day)
Number of subjects: 89
Study 18093662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 16570004 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid withdrawal group
Number of subjects: 300
Study 16570004 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 12898007 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg orally twice daily for 4 days
Number of subjects: 10
Study 10725065 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoral (microemulsion formulation of cyclosporin A)
Number of subjects: 0
Study 10725065 — intervention group
Group type: COMPARATOR
Intervention: Sandimmun (original formulation of cyclosporin A)
Number of subjects: 0
Study 9407976 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-cm J-pouch
Number of subjects: 59
Study 9407976 — intervention group
Group type: COMPARATOR
Intervention: 10-cm J-pouch
Number of subjects: 59
Study 7965224 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched TPN (53% BCAA)
Number of subjects: 10
Study 7965224 — intervention group
Group type: COMPARATOR
Intervention: Standard TPN (30% BCAA)
Number of subjects: 10
Study 2438997 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel oral rehydration mixture based on fruit juice cordial
Number of subjects: 0
Study 29626933 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN to develop an individualized eating plan (Group A)
Number of subjects: 108
Study 29626933 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN and a structured meal plan (Group B)
Number of subjects: 108
Study 29626933 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Therapy with RDN, a structured meal plan, and weekly phone support (Group C)
Number of subjects: 108
Study 27613582 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 5135
Study 27613582 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus (DM)
Number of subjects: 5135
Study 27613582 — intervention group
Group type: COMPARATOR
Intervention: Normal glucose
Number of subjects: 5135
Study 25974092 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care program (Progetto Diabete Calabria)
Number of subjects: 312
Study 25974092 — intervention group
Group type: COMPARATOR
Intervention: Ordinary outpatient medical management
Number of subjects: 312
Study 23823799 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine (25-50 mg/d)
Number of subjects: 324
Study 23823799 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (10-20 mg/d)
Number of subjects: 324
Study 21411474 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive structure (various combinations of individual and pair compensation)
Number of subjects: 224
Study 21411474 — intervention group
Group type: COMPARATOR
Intervention: Web vs. mail data collection mode
Number of subjects: 224
Study 21411474 — intervention group
Group type: COMPARATOR
Intervention: Short vs. long questionnaire length
Number of subjects: 224
Study 21411474 — intervention group
Group type: COMPARATOR
Intervention: Incentive structures (4 different combinations)
Number of subjects: 224
Study 18312763 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg
Number of subjects: 498
Study 18312763 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 160 mg
Number of subjects: 498
Study 18312763 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg and Fenofibrate 160 mg (Combination therapy)
Number of subjects: 498
Study 16768549 — intervention group
Group type: EXPERIMENTAL
Intervention: Polychromatic light (480-3400 nm) at a therapeutic dose of 12 J/cm²
Number of subjects: 0
Study 16768549 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro irradiation of blood (2.4 J/cm²)
Number of subjects: 0
Study 16768549 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated blood mixed 1:10 with nonirradiated autologous blood
Number of subjects: 0
Study 14605061 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery (LVRS)
Number of subjects: 10
Study 14605061 — intervention group
Group type: COMPARATOR
Intervention: Lobectomy (control group)
Number of subjects: 10
Study 11149164 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight control of diabetes
Number of subjects: 0
Study 11149164 — intervention group
Group type: EXPERIMENTAL
Intervention: Photocoagulation laser therapy
Number of subjects: 0
Study 11149164 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt diagnosis and treatment for endophthalmitis and mucormycosis
Number of subjects: 0
Study 11149164 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergent ophthalmologic evaluation and treatment for herpes zoster infection
Number of subjects: 0
Study 8731519 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg DMT fumarate
Number of subjects: 13
Study 8731519 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 13
Study 8329110 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal lymphocyte immunization (400 million paternal lymphocytes)
Number of subjects: 0
Study 8329110 — intervention group
Group type: COMPARATOR
Intervention: Maternal (autologous) lymphocyte immunization (400 million maternal lymphocytes)
Number of subjects: 0
Study 2945967 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based approach
Number of subjects: 8
Study 2945967 — intervention group
Group type: COMPARATOR
Intervention: Traditional intervention techniques
Number of subjects: 8
Study 30844986 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration in the direction of the resultant muscle forces' vector (VDF) at frequencies of 10, 20, 30, or 40 Hz
Number of subjects: 20
Study 30844986 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole‐body vibration (WBV) at frequencies of 10, 20, 30, or 40 Hz
Number of subjects: 20
Study 30844986 — intervention group
Group type: COMPARATOR
Intervention: Maximal voluntary contractions (MVCs) without vibration
Number of subjects: 20
Study 30074002 — intervention group
Group type: EXPERIMENTAL
Intervention: Gutta‐percha with AH Plus
Number of subjects: 56
Study 30074002 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilon with Epiphany SE
Number of subjects: 56
Study 27259529 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless securement devices
Number of subjects: 328
Study 27259529 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated securement dressings
Number of subjects: 328
Study 27259529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue adhesive
Number of subjects: 328
Study 27259529 — intervention group
Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 328
Study 24990296 — intervention group
Group type: EXPERIMENTAL
Intervention: LED curing modes (conventional, pulse-delay, ramped)
Number of subjects: 100
Study 24990296 — intervention group
Group type: COMPARATOR
Intervention: QTH curing
Number of subjects: 100
Study 22858744 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-Stirrup ankle brace
Number of subjects: 45
Study 22858744 — intervention group
Group type: COMPARATOR
Intervention: Fiberglass posterior splint
Number of subjects: 45
Study 19577308 — intervention group
Group type: EXPERIMENTAL
Intervention: SRI treatment (clomipramine, fluvoxamine, or fluoxetine)
Number of subjects: 165
Study 18664593 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (3 sessions/wk; running at 60 and 90% of peak oxygen consumption in 4-min intervals for a total of 32 min; gross energy expenditure: 446+/‐29 kcal)
Number of subjects: 7
Study 18664593 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training
Number of subjects: 7
Study 18664593 — intervention group
Group type: COMPARATOR
Intervention: Nonexercising control group (n=8)
Number of subjects: 7
Study 16200596 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 120
Study 16200596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 12954464 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 days interval
Number of subjects: 70
Study 12954464 — intervention group
Group type: COMPARATOR
Intervention: 2 weeks interval
Number of subjects: 70
Study 11789183 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi Yangyin Huoxue recipe (YQYYHX)
Number of subjects: 41
Study 11789183 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 9010690 — intervention group
Group type: EXPERIMENTAL
Intervention: ketoprofen 3 x 25 mg per day
Number of subjects: 12
Study 9010690 — intervention group
Group type: EXPERIMENTAL
Intervention: ketoprofen 3 x 50 mg per day
Number of subjects: 12
Study 9010690 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 3 x 200 mg per day
Number of subjects: 12
Study 9010690 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 3 x 400 mg per day
Number of subjects: 12
Study 1504643 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (50 micrograms/70 kg)
Number of subjects: 6
Study 1504643 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 6
Study 6421508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 2 g/l
Number of subjects: 8
Study 6421508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 20 g/l
Number of subjects: 8
Study 6421508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) 40 g/l
Number of subjects: 8
Study 6421508 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 8
Study 31443961 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant docetaxel 75 mg/m2 every 3 weeks for 6 cycles (arm A)
Number of subjects: 376
Study 31443961 — intervention group
Group type: COMPARATOR
Intervention: Surveillance (arm B)
Number of subjects: 376
Study 31443961 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant docetaxel (arm A)
Number of subjects: 376
Study 29480202 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-medical sport university site providing free access to group exercise in a sports environment
Number of subjects: 0
Study 29480202 — intervention group
Group type: COMPARATOR
Intervention: Memory clinics linked to hospitals
Number of subjects: 0
Study 27191518 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard educational session
Number of subjects: 40
Study 27191518 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard information and brochure
Number of subjects: 40
Study 27191518 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard information and informative video
Number of subjects: 40
Study 25421903 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cost bubble CPAP device
Number of subjects: 0
Study 25421903 — intervention group
Group type: COMPARATOR
Intervention: Nasal oxygen therapy
Number of subjects: 0
Study 22298340 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Voluntary Counseling and Testing (EVCT)
Number of subjects: 295
Study 22298340 — intervention group
Group type: COMPARATOR
Intervention: Standard Voluntary Counseling and Testing (SVCT)
Number of subjects: 295
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Slimming World
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosemary Conley
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Size Down (group-based dietetics-led programme)
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: General practice one-to-one counselling
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy-led one-to-one counselling
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of any of the 6 programmes
Number of subjects: 740
Study 20663185 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention control (12 vouchers for local leisure centre)
Number of subjects: 740
Study 20663185 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 740
Study 18928633 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid treatment (n = 35)
Number of subjects: 100
Study 18928633 — intervention group
Group type: COMPARATOR
Intervention: Anti-HP treatment (n = 30)
Number of subjects: 100
Study 18928633 — intervention group
Group type: COMPARATOR
Intervention: Combined treatment (glucocorticoid + HP eradication, n = 35)
Number of subjects: 100
Study 18928633 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 healthy individuals)
Number of subjects: 100
Study 15812603 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively valenced slides
Number of subjects: 15
Study 15812603 — intervention group
Group type: COMPARATOR
Intervention: Neutral slides
Number of subjects: 15
Study 15812603 — intervention group
Group type: EXPERIMENTAL
Intervention: Positively valenced slides
Number of subjects: 15
Study 12421156 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal tint glasses
Number of subjects: 17
Study 12421156 — intervention group
Group type: COMPARATOR
Intervention: Control tint glasses
Number of subjects: 17
Study 10512960 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported overdenture (IOD)
Number of subjects: 89
Study 10512960 — intervention group
Group type: COMPARATOR
Intervention: Conventional denture (CD)
Number of subjects: 89
Study 7796075 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary therapy
Number of subjects: 15
Study 1838281 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental resin sealant (ICI 209085)
Number of subjects: 60
Study 1838281 — intervention group
Group type: COMPARATOR
Intervention: Light Cured Tinted Delton (control)
Number of subjects: 60
Study 6512581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathoracic BCG
Number of subjects: 473
Study 6512581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 473
Study 31179883 — intervention group
Group type: EXPERIMENTAL
Intervention: TURis
Number of subjects: 168
Study 31179883 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 168
Study 28495389 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics scenario
Number of subjects: 132
Study 28495389 — intervention group
Group type: EXPERIMENTAL
Intervention: Equipoise scenario
Number of subjects: 132
Study 28495389 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine-hesitancy scenario
Number of subjects: 132
Study 28495389 — intervention group
Group type: COMPARATOR
Intervention: Overall comparison
Number of subjects: 132
Study 26102259 — intervention group
Group type: EXPERIMENTAL
Intervention: Packs
Number of subjects: 8
Study 26102259 — intervention group
Group type: EXPERIMENTAL
Intervention: Vest
Number of subjects: 8
Study 26102259 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 22425732 — intervention group
Group type: EXPERIMENTAL
Intervention: Step stool
Number of subjects: 50
Study 19010622 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-acetonemic diet
Number of subjects: 1200
Study 19010622 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diet intervention)
Number of subjects: 1200
Study 17551901 — intervention group
Group type: EXPERIMENTAL
Intervention: High cut-off hemodialysis (HCO-HD)
Number of subjects: 10
Study 17551901 — intervention group
Group type: COMPARATOR
Intervention: Standard high-flux hemodialysis (HF-HD)
Number of subjects: 10
Study 15185877 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug (ranitidine, 150 mg b.d.)
Number of subjects: 75
Study 15185877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 11346473 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐mediated interactive voice response (IVR) system integrated with voicemail; 18-month study duration.
Number of subjects: 100
Study 11346473 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned);
Number of subjects: 100
Study 9701194 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-chain fructans (10-30 g)
Number of subjects: 10
Study 9701194 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain fructans (10-30 g)
Number of subjects: 10
Study 9701194 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 10
Study 9701194 — intervention group
Group type: COMPARATOR
Intervention: Fructose (50 g)
Number of subjects: 10
Study 9701194 — intervention group
Group type: COMPARATOR
Intervention: Sorbitol with equimolar glucose
Number of subjects: 10
Study 9701194 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-chain fructans
Number of subjects: 10
Study 9701194 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain fructans
Number of subjects: 10
Study 7977881 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate reduced-dose group (average 11.5 mg every 2 weeks)
Number of subjects: 43
Study 7977881 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine decanoate control group (23 mg every 2 weeks)
Number of subjects: 43
Study 2521321 — intervention group
Group type: EXPERIMENTAL
Intervention: Microgynon 30
Number of subjects: 100
Study 2521321 — intervention group
Group type: EXPERIMENTAL
Intervention: Marvelon
Number of subjects: 100
Study 2521321 — intervention group
Group type: EXPERIMENTAL
Intervention: Triquilar
Number of subjects: 100
Study 1071665 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine administration
Number of subjects: 0
Study 1071665 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol administration
Number of subjects: 0
Study 1071665 — intervention group
Group type: COMPARATOR
Intervention: Normotensive control subjects (no intervention)
Number of subjects: 0
Study 30832288 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-24)
Number of subjects: 60
Study 30832288 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-42)
Number of subjects: 60
Study 30832288 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC-56)
Number of subjects: 60
Study 30832288 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60
Study 27552500 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1% 3 times daily for 1 week
Number of subjects: 132
Study 27552500 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% 3 times daily for 1 week
Number of subjects: 132
Study 27552500 — intervention group
Group type: COMPARATOR
Intervention: No anti-inflammatory treatment
Number of subjects: 132
Study 26312576 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 1.0 U
Number of subjects: 80
Study 26312576 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 2.5 U
Number of subjects: 80
Study 26312576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 26312576 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 26312576 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 80
Study 24035633 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 160 mg/day
Number of subjects: 267
Study 24035633 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 267
Study 24035633 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (200-800 mg)
Number of subjects: 267
Study 24035633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 24035633 — intervention group
Group type: COMPARATOR
Intervention: All treatments (Lurasidone 80 mg, Lurasidone 160 mg, Quetiapine XR, Placebo)
Number of subjects: 267
Study 24035633 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (40-160 mg)
Number of subjects: 267
Study 22123802 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (omeprazole, amoxicillin trihydrate, and clarithromycin) for 10 days
Number of subjects: 404
Study 22123802 — intervention group
Group type: COMPARATOR
Intervention: Control (omeprazole plus placebo) for 10 days
Number of subjects: 404
Study 19018785 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol
Number of subjects: 56
Study 19018785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Number of subjects: 56
Study 18089259 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching music videos with thin models
Number of subjects: 87
Study 18089259 — intervention group
Group type: COMPARATOR
Intervention: Listening to music from the videos
Number of subjects: 87
Study 18089259 — intervention group
Group type: COMPARATOR
Intervention: Learning a list of words
Number of subjects: 87
Study 15257176 — intervention group
Group type: EXPERIMENTAL
Intervention: rilmenidine 1 mg twice daily
Number of subjects: 15
Study 15257176 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 11166979 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 150
Study 11166979 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 20 mg
Number of subjects: 150
Study 11166979 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen 50 mg
Number of subjects: 150
Study 11166979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150